Serum citrulline and rejection in small bowel transplantation: A preliminary report

Peter A. Pappas, Jean Marie Saudubray, Andreas G. Tzakis, Daniel Rabier, Manuel R. Carreno, Orlando Gomez-Marin, Frans Huijing, Barry Gelman, David M. Levi, Jose R. Nery, Tomoaki Kato, Naveen Mittal, Seigo Nishida, John F. Thompson, Phillip Ruiz

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Background. There is no known serum marker for intestinal rejection. Serum concentrations of the amino acid citrulline arise almost exclusively from the intestinal mucosa. We examined the impact of acute cellular rejection (ACR) of intestinal allografts on serum citrulline levels. Methods. Citrulline concentrations were assayed in serum samples of healthy volunteers (n=6) and seven patients who underwent small bowel transplants (SBTx). Trends in mean citrulline concentrations versus degree of ACR were assessed by matching posttransplantation citrulline concentrations with patients' grade of ACR at time of serum collection. Rejection was confirmed by biopsy and graded by following standardized criteria. An additional patient had citrulline concentrations determined for 31 sequential specimens 3-60 days posttransplant. Results. Mean citrulline concentrations in controls were significantly higher than posttransplantation samples at any rejection grade. Mean concentrations declined significantly as rejection severity increased. The overall downward trend was statistically significant (P<0.05). In sequential measurements, citrulline levels increased significantly over time with declining severity of rejection. The increase in mean citrulline concentration between posttransplant days 3-16 and 52-60 was significant (P<0.01). Conclusions. Serum citrulline levels decline with increasing grade of ACR and may be a useful serum marker for intestinal rejection.

Original languageEnglish (US)
Pages (from-to)1212-1216
Number of pages5
JournalTransplantation
Volume72
Issue number7
StatePublished - Oct 15 2001
Externally publishedYes

Fingerprint

Citrulline
Transplantation
Serum
Biomarkers
Intestinal Mucosa
Allografts
Healthy Volunteers
Transplants
Biopsy
Amino Acids

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Pappas, P. A., Saudubray, J. M., Tzakis, A. G., Rabier, D., Carreno, M. R., Gomez-Marin, O., ... Ruiz, P. (2001). Serum citrulline and rejection in small bowel transplantation: A preliminary report. Transplantation, 72(7), 1212-1216.

Serum citrulline and rejection in small bowel transplantation : A preliminary report. / Pappas, Peter A.; Saudubray, Jean Marie; Tzakis, Andreas G.; Rabier, Daniel; Carreno, Manuel R.; Gomez-Marin, Orlando; Huijing, Frans; Gelman, Barry; Levi, David M.; Nery, Jose R.; Kato, Tomoaki; Mittal, Naveen; Nishida, Seigo; Thompson, John F.; Ruiz, Phillip.

In: Transplantation, Vol. 72, No. 7, 15.10.2001, p. 1212-1216.

Research output: Contribution to journalArticle

Pappas, PA, Saudubray, JM, Tzakis, AG, Rabier, D, Carreno, MR, Gomez-Marin, O, Huijing, F, Gelman, B, Levi, DM, Nery, JR, Kato, T, Mittal, N, Nishida, S, Thompson, JF & Ruiz, P 2001, 'Serum citrulline and rejection in small bowel transplantation: A preliminary report', Transplantation, vol. 72, no. 7, pp. 1212-1216.
Pappas PA, Saudubray JM, Tzakis AG, Rabier D, Carreno MR, Gomez-Marin O et al. Serum citrulline and rejection in small bowel transplantation: A preliminary report. Transplantation. 2001 Oct 15;72(7):1212-1216.
Pappas, Peter A. ; Saudubray, Jean Marie ; Tzakis, Andreas G. ; Rabier, Daniel ; Carreno, Manuel R. ; Gomez-Marin, Orlando ; Huijing, Frans ; Gelman, Barry ; Levi, David M. ; Nery, Jose R. ; Kato, Tomoaki ; Mittal, Naveen ; Nishida, Seigo ; Thompson, John F. ; Ruiz, Phillip. / Serum citrulline and rejection in small bowel transplantation : A preliminary report. In: Transplantation. 2001 ; Vol. 72, No. 7. pp. 1212-1216.
@article{b88a9b46a3e843b3bd6c0f4cd4bf64d7,
title = "Serum citrulline and rejection in small bowel transplantation: A preliminary report",
abstract = "Background. There is no known serum marker for intestinal rejection. Serum concentrations of the amino acid citrulline arise almost exclusively from the intestinal mucosa. We examined the impact of acute cellular rejection (ACR) of intestinal allografts on serum citrulline levels. Methods. Citrulline concentrations were assayed in serum samples of healthy volunteers (n=6) and seven patients who underwent small bowel transplants (SBTx). Trends in mean citrulline concentrations versus degree of ACR were assessed by matching posttransplantation citrulline concentrations with patients' grade of ACR at time of serum collection. Rejection was confirmed by biopsy and graded by following standardized criteria. An additional patient had citrulline concentrations determined for 31 sequential specimens 3-60 days posttransplant. Results. Mean citrulline concentrations in controls were significantly higher than posttransplantation samples at any rejection grade. Mean concentrations declined significantly as rejection severity increased. The overall downward trend was statistically significant (P<0.05). In sequential measurements, citrulline levels increased significantly over time with declining severity of rejection. The increase in mean citrulline concentration between posttransplant days 3-16 and 52-60 was significant (P<0.01). Conclusions. Serum citrulline levels decline with increasing grade of ACR and may be a useful serum marker for intestinal rejection.",
author = "Pappas, {Peter A.} and Saudubray, {Jean Marie} and Tzakis, {Andreas G.} and Daniel Rabier and Carreno, {Manuel R.} and Orlando Gomez-Marin and Frans Huijing and Barry Gelman and Levi, {David M.} and Nery, {Jose R.} and Tomoaki Kato and Naveen Mittal and Seigo Nishida and Thompson, {John F.} and Phillip Ruiz",
year = "2001",
month = "10",
day = "15",
language = "English (US)",
volume = "72",
pages = "1212--1216",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Serum citrulline and rejection in small bowel transplantation

T2 - A preliminary report

AU - Pappas, Peter A.

AU - Saudubray, Jean Marie

AU - Tzakis, Andreas G.

AU - Rabier, Daniel

AU - Carreno, Manuel R.

AU - Gomez-Marin, Orlando

AU - Huijing, Frans

AU - Gelman, Barry

AU - Levi, David M.

AU - Nery, Jose R.

AU - Kato, Tomoaki

AU - Mittal, Naveen

AU - Nishida, Seigo

AU - Thompson, John F.

AU - Ruiz, Phillip

PY - 2001/10/15

Y1 - 2001/10/15

N2 - Background. There is no known serum marker for intestinal rejection. Serum concentrations of the amino acid citrulline arise almost exclusively from the intestinal mucosa. We examined the impact of acute cellular rejection (ACR) of intestinal allografts on serum citrulline levels. Methods. Citrulline concentrations were assayed in serum samples of healthy volunteers (n=6) and seven patients who underwent small bowel transplants (SBTx). Trends in mean citrulline concentrations versus degree of ACR were assessed by matching posttransplantation citrulline concentrations with patients' grade of ACR at time of serum collection. Rejection was confirmed by biopsy and graded by following standardized criteria. An additional patient had citrulline concentrations determined for 31 sequential specimens 3-60 days posttransplant. Results. Mean citrulline concentrations in controls were significantly higher than posttransplantation samples at any rejection grade. Mean concentrations declined significantly as rejection severity increased. The overall downward trend was statistically significant (P<0.05). In sequential measurements, citrulline levels increased significantly over time with declining severity of rejection. The increase in mean citrulline concentration between posttransplant days 3-16 and 52-60 was significant (P<0.01). Conclusions. Serum citrulline levels decline with increasing grade of ACR and may be a useful serum marker for intestinal rejection.

AB - Background. There is no known serum marker for intestinal rejection. Serum concentrations of the amino acid citrulline arise almost exclusively from the intestinal mucosa. We examined the impact of acute cellular rejection (ACR) of intestinal allografts on serum citrulline levels. Methods. Citrulline concentrations were assayed in serum samples of healthy volunteers (n=6) and seven patients who underwent small bowel transplants (SBTx). Trends in mean citrulline concentrations versus degree of ACR were assessed by matching posttransplantation citrulline concentrations with patients' grade of ACR at time of serum collection. Rejection was confirmed by biopsy and graded by following standardized criteria. An additional patient had citrulline concentrations determined for 31 sequential specimens 3-60 days posttransplant. Results. Mean citrulline concentrations in controls were significantly higher than posttransplantation samples at any rejection grade. Mean concentrations declined significantly as rejection severity increased. The overall downward trend was statistically significant (P<0.05). In sequential measurements, citrulline levels increased significantly over time with declining severity of rejection. The increase in mean citrulline concentration between posttransplant days 3-16 and 52-60 was significant (P<0.01). Conclusions. Serum citrulline levels decline with increasing grade of ACR and may be a useful serum marker for intestinal rejection.

UR - http://www.scopus.com/inward/record.url?scp=0035886295&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035886295&partnerID=8YFLogxK

M3 - Article

C2 - 11602844

AN - SCOPUS:0035886295

VL - 72

SP - 1212

EP - 1216

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 7

ER -